In Utero Exposure to 17α-Hydroxyprogesterone Caproate May Contribute to Increasing Incidence Rates of Early-Onset Cancer

Background: 17α-hydroxyprogesterone caproate (17-OHPC) is a synthetic progestogen introduced in the 1950s to treat habitual and threatened abortion in pregnant women. Although 17-OHPC is still available (tradename Makena), little is known about its effects on health of adult offspring, and questions...

Full description

Saved in:
Bibliographic Details
Published in:J Endocr Soc
Main Authors: Murphy, Caitlin C, Cirillo, Piera M, Krigbaum, Nickilou Y, Cohn, Barbara
Format: Artigo
Language:Inglês
Published: Oxford University Press 2021
Subjects:
Endocrine Disruption
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC8090668/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1210/jendso/bvab048.1014
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items